Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | mollevi |
|---|---|
| Group name | EquipePC |
| Item Type | Note |
| Note | Marchant, Julie |
| Date Added | 2018/11/14 - 12:07:50 |
| Date Modified | 2018/11/14 - 12:07:50 |
| Parent item | Comparative evaluation of the new FDA approved THxID-BRAF test with High Resolution Melting and Sanger sequencing |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de